Effect of dexmedetomidine on lower extremity ischemia/refusion injury due to tourniquet application during arthroscopy
CHEN Hui1, HAO Nannan2, and LEI Zhili1
1.Department of Anesthesiology,General Hospital of Chinese People’s Armed Police Force,Beijing 100039,China 2. The Key Laboratory of Anesthesiology & Institute of Anesthesiology of Jiangsu Province, Xuzhou Medical College, Xuzhou 221004, China
Abstract:Objective To analyze the effect of dexmedetomidine on the level of serum inflammation cytokines and oxygen free radicals during lower extremity ischemia/refusion.Methods The study was performed on patients undergoing arthroscopic operation under spinal anesthesia. Forty patients were randomly allocated into two groups: Group control (C,n=20) and Group dexmedetomidine (D,n=20). In Group D, patients were sedated with dexmedetomidine at a continuous infusion [1 μg/kg for 10 minutes, followed by 1 μg/(kg·h)] until the end of surgery, whereas the control group received an equivalent volume of saline. Femoral venous blood samples were obtained before spinal anesthesia(T0), at tourniquet inflation 1 h(T1), after tourniquet deflation 20 minutes(T2) ,1 h(T3) and 6 h(T4) .Then the serum concentrations of SOD,MDA,TNF-α and IL-6 were measured.Results Serum SOD activity was significantly higher in the group D after tourniquet deflation 1 h and 6 h compared with those of in the group C (P<0.05) .There was a significant lowering in the serum SOD activity after tourniquet deflation 1 h and 6 h compared with the baseline in the group C(P<0.05). Serum MDA was significantly greater during ischemia and reperfusion period in the control group compared with the baseline (P<0.05) and significantly attenuated in the group D after tourniquet deflation 1 h (P<0.05) and 6 h (P<0.05).Serum TNF-α was highly elevated during ischemia and reperfusion period in the control group and the group D compared with the baseline(P<0.05) and the decrease was significantly observed in the group D compared with the group C after deflation 6 h(P<0.05). Secrum IL-6 was not significantly different in both groups at tourniquet inflation 1 h and deflation 20 min’and 1 h compared with baseline. There was a significantly greater level of IL-6 after tourniquet deflation 6 h compared with the baseline and compared with the group D (P<0.05).Conclusions Dexmedetomidine may offer advantages by inhibiting lipid peroxidation and attenuating the production of inflammatory cytokines during lower extremity ischemia/refusion injury due to tourniquet application .
陈晖, 郝楠楠, 雷志礼. 右美托咪定对止血带诱发下肢缺血再灌注损伤的影响[J]. 武警医学, 2016, 27(8): 826-829.
CHEN Hui, HAO Nannan, and LEI Zhili. Effect of dexmedetomidine on lower extremity ischemia/refusion injury due to tourniquet application during arthroscopy. Med. J. Chin. Peop. Armed Poli. Forc., 2016, 27(8): 826-829.
Seybold E A, Busconi B D. Anterior thigh compartment syndromefollowing prolonged tourniquet application and lateral positioning[J].Am J Orthop ,1996,25:493-496.
[2]
Yassin M M, Harkin D W, Barros A A, et al. Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction[J]. World J Surg,2002,26(1):115-121
[3]
Gutteridge J M. Lipid peroxidation and antioxidants as biomarkers oftissue damage[J]. Clin Chem ,1995,41:1819-1828.
[4]
Uysal H Y, Cuzdan S S, Kayíran O, et al. Preventive effect of Dexmedetomidine in ischemia-reperfusion injury[J]. J Craniofac Surg, 2012 ,23(5):1287-1291.
[5]
Yagmurdur H, Ozcan N, Dokumaci F, et al. Dexmedetomidine reduces the ischemia-reperfusion injury markers during upper extremity surgery with tourniquet[J]. J Hand Surg Am, 2008,33(6):941-947.
[6]
Lan W, Harmon D, Wang J H, et al. The effect of lidocaine on in vitro neutrophil and endothelial adhesion molecule expression induced by plasma obtained during tourniquetinducedischaemia and reperfusion[J]. Eur J Anaesthesiol, 2004,21: 892-897.
[7]
McIntyre T M, Patel K D, Zimmerman G A, et al. radical-mediated leukocyte adherence. In: Granger DN, Schinbein GW, editors. Physiology and pathophysiology of leukocyte adhesion[J]. Oxford University Press, 1995,25: 261-277.
[8]
Frangiogiannis N G, Lindsey M L, Michael L H, et al. Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial / reperfusion[J]. Circulation ,1998;98:699-710.
[9]
Svoboda P, Kantorova I, Ochmann J. Dynamics of interleukin 1, 2, and 6 and tumor necrosis factor alpha in multiple trauma patients[J]. J Trauma,1994,36:336-340.
[10]
Leon L R, White A A, Kluger M J. Role of IL-6 and TNF in thermoregulationand survival during sepsis in mice[J]. Am J Physiol, 1998,275:269-277.
[11]
O’Riordain M G, O’Riordain D S, Molloy R G,et al.Dosage and timing of anti-TNF-alpha antibody treatmentdetermine its effect of resistance to sepsis after injury[J]. J Surg Res. 1996,64:95-101.
[12]
Biffl W L, Moore E E, Moore F A, et al. Interleukin-6 in the injured patient, Marker of injury or mediator of inflammation? [J]. Ann Surg,1996,224:647-664.